We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-2.75%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.1B
AUM Growth
+$273M
Cap. Flow
-$650M
Cap. Flow %
-4.61%
Top 10 Hldgs %
32.88%
Holding
703
New
–
Increased
221
Reduced
319
Closed
43

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$41.6M
2
NVDA icon
NVIDIA
NVDA
+$36M
3
ISRG icon
Intuitive Surgical
ISRG
+$33.8M
4
AMAT icon
Applied Materials
AMAT
+$32.4M
5
XP icon
XP
XP
+$31M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$57.8M
2
JNJ icon
Johnson & Johnson
JNJ
+$54.9M
3
DHR icon
Danaher
DHR
+$41.9M
4
MSFT icon
Microsoft
MSFT
+$40.7M
5
LRCX icon
Lam Research
LRCX
+$37.4M

Sector Composition

Rank Sector Weight
1 Healthcare 26.08%
2 Technology 25.64%
3 Financials 11.81%
4 Industrials 7.9%
5 Materials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RLAY icon
251
Relay Therapeutics
RLAY
$4B
$8.17M 0.06%
971,070
– –
KRYS icon
252
Krystal Biotech
KRYS
$10.7B
$8.12M 0.06%
70,000
– –
TSCO icon
253
Tractor Supply
TSCO
$16.3B
$8.05M 0.06%
198,325
+25,440
+15% +$1.1M
BMO icon
254
Bank of Montreal
BMO
$123B
$7.96M 0.06%
93,917
-66,815
-42% -$5.87M
ROP icon
255
Roper Technologies
ROP
$40.4B
$7.83M 0.06%
16,176
+9,770
+153% +$4.79M
ZTS icon
256
Zoetis
ZTS
$32.7B
$7.73M 0.05%
44,441
+1,476
+3% +$268K
NRIX icon
257
Nurix Therapeutics
NRIX
$2.45B
$7.61M 0.05%
968,110
-51,712
-5% -$472K
COGT icon
258
Cogent Biosciences
COGT
$6.76B
$7.53M 0.05%
777,487
+5,000
+0.6% +$59.3K
POWI icon
259
Power Integrations
POWI
$3.15B
$7.49M 0.05%
98,147
-24,884
-20% -$2.13M
DNLI icon
260
Denali Therapeutics
DNLI
$3.79B
$7.38M 0.05%
357,878
– –
CERE
261
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$7.14M 0.05%
327,221
– –
TWLO icon
262
Twilio
TWLO
$28.6B
$7.06M 0.05%
120,671
+66,997
+125% +$4.18M
FOLD
263
DELISTED
Amicus Therapeutics
FOLD
$7.04M 0.05%
578,879
-115,000
-17% -$1.48M
AMP icon
264
Ameriprise Financial
AMP
$47.8B
$7.03M 0.05%
21,325
+9,710
+84% +$3.31M
WTRG icon
265
Essential Utilities
WTRG
$11.5B
$6.96M 0.05%
202,879
+135,292
+200% +$5.24M
WFG icon
266
West Fraser Timber
WFG
$5.21B
$6.94M 0.05%
95,704
-19,429
-17% -$1.53M
DE icon
267
Deere & Co
DE
$165B
$6.93M 0.05%
18,354
-7,968
-30% -$3.29M
AZPN
268
DELISTED
Aspen Technology Inc
AZPN
$6.8M 0.05%
33,294
-8,417
-20% -$1.58M
BPMC
269
DELISTED
Blueprint Medicines
BPMC
$6.79M 0.05%
135,222
-16,000
-11% -$855K
KYMR icon
270
Kymera Therapeutics
KYMR
$8.66B
$6.79M 0.05%
488,306
– –
T icon
271
AT&T
T
$164B
$6.76M 0.05%
450,190
-4,470
-1% -$65.5K
SPG icon
272
Simon Property Group
SPG
$76.4B
$6.7M 0.05%
62,001
+1,457
+2% +$171K
INDA icon
273
iShares MSCI India ETF
INDA
$6.81B
$6.61M 0.05%
149,470
+2,870
+2% +$127K
ITW icon
274
Illinois Tool Works
ITW
$84.1B
$6.61M 0.05%
28,679
-951
-3% -$232K
AVY icon
275
Avery Dennison
AVY
$12.8B
$6.6M 0.05%
36,148
+4,137
+13% +$749K
9 10
11
12 13

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2023 Portfolio in Review

As of Q3 2023, Candriam SCA held 703 positions worth $14.1B, up 2% from $13.8B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Candriam SCA withdrew a net $650M in Q3 2023, closing 43 positions and reducing 319 holdings. Its most notable exit was Chinook Therapeutics, Inc. Common Stock, an estimated $31.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA added an estimated $41.6M to Amgen.

  • Candriam SCA added most to Amgen in Q3 2023, an estimated $41.6M increase.
  • Candriam SCA's biggest Q3 2023 reduction was Visa, cutting an estimated $57.8M.
  • Candriam SCA fully exited Chinook Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $31.7M.
  • Candriam SCA's ten largest holdings make up 33% of its $14.1B portfolio in Q3 2023.
  • Candriam SCA opened 0 new positions and closed 43 in Q3 2023.
  • Candriam SCA's portfolio value rose 2% quarter-over-quarter to $14.1B.

Based on Candriam SCA's 13F filing for Q3 2023, filed 13 Nov 2023.